Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy
- PMID: 15172083
- DOI: 10.1016/S0378-5122(03)00187-7
Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy
Abstract
Objective: To assess if regular physical exercise or oral oestradiol therapy decreased vasomotor symptoms and increased quality of life in previously sedentary postmenopausal women.
Setting: A prospective, randomised trial at a University Hospital.
Methods: 75 postmenopausal, sedentary women with vasomotor symptoms were randomised to: exercise three-times weekly over 12 weeks (15 women), oral oestradiol therapy for 12 weeks (15 women) and 45 women to three other treatment arms. Results from the exercise and oestradiol groups are presented here. The effects on vasomotor symptoms and wellbeing were assessed with logbooks and validated questionnaires.
Results: Ten women fulfilled 12 weeks of exercise. The number of flushes was rather unchanged in five women and decreased to 28% (range 18-42%) of baseline in the other five women. Five of the ten women continued to exercise another 24 weeks, thus in all 36 weeks. The mean number of flushes decreased by about 50% in these five women (from 6.2/24 to 3.2 flushes/24 h at 36 weeks). In the same group a score made as the product of reduction in number and severity of flushes decreased by 92% at 12 weeks, 75% at 24 weeks and 72% at 36 weeks compared with baseline. In the estrogen group flushes decreased from 8.4 to 0.8 (P<0.001) after 12 weeks of therapy and remained at this level after 36 weeks. Well-being according to different measurements improved significantly in both groups, albeit more markedly in the estrogen group.
Conclusions: Apart from many other health benefits regular physical exercise may decrease vasomotor symptoms and increase quality of life in postmenopausal women, but this has to be further evaluated scientifically. Exercise should be introduced gradually to ensure compliance.
Similar articles
-
Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women.Maturitas. 2005 Jun 16;51(2):154-62. doi: 10.1016/j.maturitas.2004.05.017. Maturitas. 2005. PMID: 15917156 Clinical Trial.
-
The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.BJOG. 2003 Aug;110(8):753-9. BJOG. 2003. PMID: 12892687 Clinical Trial.
-
Effects of acupuncture, applied relaxation, estrogens and placebo on hot flushes in postmenopausal women: an analysis of two prospective, parallel, randomized studies.Climacteric. 2007 Feb;10(1):38-45. doi: 10.1080/13697130601165059. Climacteric. 2007. PMID: 17364603 Clinical Trial.
-
Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.Obstet Gynecol. 2004 Feb;103(2):267-73. doi: 10.1097/01.AOG.0000110247.98588.ff. Obstet Gynecol. 2004. PMID: 14754694 Clinical Trial.
-
Maintaining functionality in later years: a review of nutrition and physical activity interventions in postmenopausal women.J Nutr Elder. 2010 Jul;29(3):259-92. doi: 10.1080/01639366.2010.499093. J Nutr Elder. 2010. PMID: 20711923 Review.
Cited by
-
Exercise participation, body mass index, and health-related quality of life in women of menopausal age.Br J Gen Pract. 2007 Feb;57(535):130-5. Br J Gen Pract. 2007. PMID: 17266830 Free PMC article.
-
Short-term exercise approaches on menopausal symptoms, psychological health, and quality of life in postmenopausal women.Obstet Gynecol Int. 2010;2010:274261. doi: 10.1155/2010/274261. Epub 2010 Aug 16. Obstet Gynecol Int. 2010. PMID: 20814541 Free PMC article.
-
Management of menopausal hot flushes. Recommendations from the Spanish Menopause Society.Eur J Obstet Gynecol Reprod Biol X. 2025 Jan 23;25:100366. doi: 10.1016/j.eurox.2025.100366. eCollection 2025 Mar. Eur J Obstet Gynecol Reprod Biol X. 2025. PMID: 39944633 Free PMC article. Review.
-
Hot flashes: a review of pathophysiology and treatment modalities.Oncologist. 2011;16(11):1658-64. doi: 10.1634/theoncologist.2011-0174. Epub 2011 Oct 31. Oncologist. 2011. PMID: 22042786 Free PMC article. Review.
-
Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66.BJOG. 2022 Jan;129(1):e16-e34. doi: 10.1111/1471-0528.16896. Epub 2021 Oct 20. BJOG. 2022. PMID: 34672090 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical